Reverse merger · Completed · NTBL

Notable Labs, Inc.

Reverse merger with Vascular Biogenics Ltd. (VBLT)

Notable Labs, Inc. merged into Vascular Biogenics Ltd. (VBLT), a Nasdaq-listed clinical-stage biotech that had sold its manufacturing facility, in a reverse merger that takes the private company public. The deal was announced on Feb 22, 2023 and closed on Oct 16, 2023. The combined company trades as Notable Labs, Ltd. (NTBL) on Nasdaq.

Notable Labs is a clinical-stage company developing predictive precision medicines for cancer patients, using its platform to guide and speed therapeutic development. It became Nasdaq-listed through its merger with Vascular Biogenics.

Status: Completed
Private company: Notable Labs, Inc.
Public company: Vascular Biogenics Ltd. (VBLT)
Public company business before: Nasdaq-listed clinical-stage biotech that had sold its manufacturing facility
Announced: Feb 22, 2023
Closed: Oct 16, 2023
Combined company: Notable Labs, Ltd. (NTBL)
Exchange: Nasdaq
Sector: Biotech & pharma

Filings

Other completed reverse mergers

Cartesian Therapeutics, Inc.into Selecta Biosciences, Inc. · Nov 13, 2023
Korro Bio, Inc.into Frequency Therapeutics, Inc. · Nov 3, 2023
Beijing Continent Pharmaceuticals Co., Ltd. (via GNI Group)into Catalyst Biosciences, Inc. · Oct 30, 2023
Tourmaline Bio, Inc.into Talaris Therapeutics, Inc. · Oct 19, 2023
Dianthus Therapeutics, Inc. (OpCo)into Magenta Therapeutics, Inc. · Sep 11, 2023
Hong Chang Global Investment Holdings Limited (Hongchang BVI)into Heyu Biological Technology Corporation · Sep 7, 2023

More on this deal for subscribers

Filings

Other completed reverse mergers